COMMUNIQUÉS West-GlobeNewswire

Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma
07/11/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma IL-4 / IL-13 Kinoid induces strong [...]
Néovacs : preuve de concept in vivo de son nouveau vaccin thérapeutique dans le traitement de l'asthme
07/11/2018
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs annonce avoir établi la preuve de concept in vivo de son nouveau vaccin thérapeutique IL-4/IL-13 Kinoi de dans le traitement de l'asthme induit [...]
Virtusa Partners with the IBRI to Drive Innovation and Accelerate Therapy Research
07/11/2018
SOUTHBOROUGH, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for [...]
New Eyes Opens Fifth Convenient Las Vegas Location in the Southwest
07/11/2018
New Eyes announces a new location in the southwest region of the Las Vegas Valley, offering a wide range of surgical and medical eye care services such as premier laser cataract surgery, corneal procedures, glaucoma [...]
Konica Minolta Announces New Tools in Exa® Enterprise Imaging Platform to Increase Clinical Productivity and Enhance Communication
07/11/2018
WAYNE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at RSNA 2018. Exa is a breakthrough solution comprised [...]
SeeThruEquity Initiates .03 Target on HempAmericana (HMPQ)
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has [...]
Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281
07/11/2018
Full data shows safety, tolerability and proof-of-mechanism in healthy volunteers CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced the publication of [...]
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud
07/11/2018
Eliminating positive foods identified by Biomerica’s diagnostic product showed statistically significant improvements (p<0.05) in both Quality of Life (FDA Instrument) and disease activity (Mayo Score) in UC patients [...]
ImmuCell to Announce Financial Results for Third Quarter of 2018
07/11/2018
Conference Call Scheduled for Wednesday, November 14, 2018 at 9:00 AM ET PORTLAND, Maine, Nov. 07, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]
Aquinox Pharmaceuticals Announces Third Quarter 2018 Financial Results
07/11/2018
VANCOUVER, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ:AQXP), a pharmaceutical company discovering and developing novel drug candidates to treat inflammation [...]
Obalon Balloon System Data to be Featured in Presentation During 35th ASMBS Annual Meeting at Obesity Week 2018
07/11/2018
Clinical results from over 1,300 patients at 108 sites treated with Obalon’s novel weight loss device solution in commercial use SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a [...]
Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value
07/11/2018
Announces 1:8 Reverse Stock Split THOROFARE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information [...]
Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®
07/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]
K2M Group Holdings, Inc. Stockholders Approve Acquisition by Stryker
07/11/2018
LEESBURG, Va., Nov. 07, 2018 (GLOBE NEWSWIRE) -- At a special meeting today, stockholders of K2M Group Holdings, Inc. (“K2M” or the “Company”) (NASDAQ: KTWO) approved the adoption of the Agreement and Plan of Merger ( [...]
CV Sciences, Inc. Reports Third Quarter 2018 Financial Results
07/11/2018
Record Sales and Gross Profit Lead Strong Quarter for CVSI 10% Sequential Sales Increase Management to Host Third Quarter 2018 Financial Results Conference Call on November 7, 2018 at 4:15pm ET LAS VEGAS, Nov. 07, 2018 [...]
Daxor Corporation Selected for U.S. Army Contract to Develop a Blood Volume Analyzer for Improvement of Combat Casualty Care
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today [...]
Precision Therapeutics Secures Rights to Novel Technology Designed To Develop Drugs That Target Specific Cancer by Its Mutation
07/11/2018
MINNEAPOLIS, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Onconova Welcomes Richard (Ric) Woodman, M.D., as Chief Medical Officer (CMO)
07/11/2018
Dr. Woodman is appointed CMO and Senior Vice President of Research & Development, joining Onconova after multiple accomplishments at Novartis Other recent hires in Clinical and Regulatory Affairs strengthen the [...]
Bellerophon Provides Business Update and Reports Third Quarter 2018 Financial Results
07/11/2018
WARREN, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today provided a business update and reported [...]

Pages